- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06261112
The Effect of Using a Kaleidoscope on Fear and Pain in Children
The Effect of the Use of Kaleidoscope on Pain and Fear in the Plastering Process of Fracture Emergencies
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Type of Study: The study was designed as a randomized controlled experimental study. Place and Time of Research:
The research was conducted between March 2022 and December 2023 as a randomized controlled experimental study. The study population consisted of patients who sought treatment at the Orthopedics Polyclinic and Emergency Department of Erzurum Atatürk University Health Research and Application Center. These patients were referred to the orthopedics clinic and diagnosed with fractures, such as humerus, wrist, finger, tibia, femur, and ankle fractures, for which plastering was performed as treatment. Specifically, the study included children aged 6 to 12 years. The sample size for the study was determined through a power analysis and ultimately consisted of a total of 70 children, with 35 children assigned to both the control group and the kaleidoscope group. The children in the kaleidoscope group were exposed to a kaleidoscope, while the control group received no intervention beyond routine medical practice. To collect data, the researchers utilized an "Introductory Information Form," the "Wong-Baker Faces Pain Rating Scale," and the "Children Fear Scale." The data were analyzed using percentage distributions, mean, standard deviation, chi-square test, and independent groups t-test. Throughout the research, ethical principles were strictly followed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Erzurum, Turkey, 25240
- Ataturk University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being a child in the 6-12 age group,
- The child's willingness to participate in the study,
- The parent's volunteering to participate in the study,
- Absence of intellectual disability of the child and parent,
- The child and the parent speak Turkish and are open to communication.
Exclusion Criteria:
- The child has a chronic disease that can cause pain,
- The child has used analgesics within 24 hours before admission to the hospital,
- The child has visual impairment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Experimental group kaleideskope, pain and fear
|
used to kaleideskope
|
|
No Intervention: No intervention group
No intervention group Control not pain and fear
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Fear Scale (CFS)
Time Frame: 12 MONTHS
|
The Child Fear Scale was developed by McMurty et al. in 2011 to measure fear in children undergoing painful medical procedures.
The Child Fear Scale is a 0-4 Likert type scale showing five different faces, ranging from neutral (0=n0 concern et all) to fearful (4=severe anxietly).
|
12 MONTHS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Facial Expressions Rating Scale
Time Frame: 12 MONTHS
|
This visual facial scale is a practical method to assess rhe level of anxiety within a situation.
There are six facial expressions, ranging from very happy to very unhappy and children are asked to choose the one that comes closest to how they feel at that moment.
The most positive face is scored as "0" and the most negative face as scored as "5".
|
12 MONTHS
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mihriban ÇULHA, Mihriban ÇULHA, graduate student ,Ataturk University
- Principal Investigator: Mihriban ÇULHA, Ataturk University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B.30.2.ATA.01.11/285
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.